Does Tricare Cover Ozempic? Insurance Guide 2026

Navigating Tricare’s prescription drug coverage can be complex, especially when it comes to high-demand medications like Ozempic. As of 2026, Tricare’s policies on Ozempic—whether for diabetes or weight loss—reflect evolving medical guidelines and cost considerations. This guide breaks down Tricare’s coverage criteria, costs, and steps to secure approval for Ozempic, ensuring beneficiaries make informed decisions about their health.

Does Tricare Cover Ozempic for Diabetes?

Tricare does cover Ozempic for beneficiaries with Type 2 diabetes, but only under specific conditions. Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in 2017 for improving glycemic control in adults with Type 2 diabetes. Tricare aligns its coverage with FDA indications, meaning Ozempic is covered when prescribed to manage blood sugar levels in diabetic patients, typically as an adjunct to diet and exercise.

To qualify, beneficiaries must provide clinical documentation demonstrating inadequate control of diabetes with first-line therapies like metformin. Tricare may require evidence of HbA1c levels above target (usually >7%) despite prior treatment. Additionally, Ozempic is often covered only after failure of other GLP-1 agonists or insulin therapies, reflecting a step-therapy approach to minimize costs.

As of 2026, Tricare’s formulary lists Ozempic under its Tier 3 medications, which may involve higher copayments. However, coverage is generally consistent across Tricare Prime, Select, and other plans, though prior authorization is almost always required. Beneficiaries should consult their provider to ensure their prescription meets Tricare’s medical necessity criteria for Ozempic.

Does Tricare Cover Ozempic for Weight Loss?

Tricare does not cover Ozempic solely for weight loss, but there are exceptions. Ozempic is not FDA-approved for obesity treatment; its sister drug, Wegovy (also semaglutide), is the approved version for chronic weight management. However, Tricare may approve Ozempic for weight loss in specific clinical scenarios, such as when a beneficiary has Type 2 diabetes and obesity (BMI ≥30 or ≥27 with weight-related comorbidities).

In these cases, Ozempic’s weight-loss benefits are considered secondary to its primary indication for diabetes management. Tricare’s policy mirrors Medicare and many commercial insurers, which typically deny coverage for Ozempic when prescribed off-label for obesity. However, if a provider documents that weight loss is medically necessary to improve diabetes outcomes, Tricare may approve the prescription under its diabetes coverage criteria.

For beneficiaries without diabetes, Tricare will not cover Ozempic for weight loss. Alternatives like Wegovy or lifestyle interventions may be recommended, though Wegovy’s coverage under Tricare is also limited and subject to strict prior authorization. Beneficiaries should work closely with their healthcare team to explore covered options for weight management.

How Much Does Ozempic Cost With Tricare?

The cost of Ozempic with Tricare depends on the beneficiary’s specific plan, pharmacy network, and whether prior authorization is approved. As a Tier 3 medication on Tricare’s formulary, Ozempic is classified as a non-preferred brand-name drug, which typically incurs higher out-of-pocket costs. In 2026, beneficiaries can expect the following cost structures:

• Tricare Prime: For active-duty service members and their families, Ozempic is often available at no cost when filled at a military pharmacy. However, if obtained through a retail or mail-order pharmacy, copayments may apply. As of 2026, the copayment for Tier 3 drugs is $38 for a 30-day supply at retail pharmacies and $25 for a 90-day supply via mail order.
• Tricare Select: Beneficiaries under Tricare Select face higher costs. The copayment for Tier 3 drugs is $60 for a 30-day supply at retail pharmacies and $40 for a 90-day supply via mail order. Additionally, Select beneficiaries must meet their annual deductible before copayments apply.
• Catastrophic Cap: Tricare’s catastrophic cap limits annual out-of-pocket expenses. For active-duty families, the cap is $1,000 per fiscal year; for retirees and their families, it is $3,000. Once met, Ozempic and other covered medications are free for the remainder of the year.

Without insurance, Ozempic costs $1,000–$1,300 per month, making Tricare’s coverage essential for affordability. Beneficiaries should verify costs with their pharmacy and consider using Tricare’s Express Scripts mail-order service to reduce expenses.

Ozempic Prior Authorization for Tricare

Prior authorization is mandatory for Ozempic under Tricare, regardless of whether it is prescribed for diabetes or weight loss. This process ensures the medication is medically necessary and cost-effective before coverage is approved. To obtain prior authorization for Ozempic, providers must submit clinical documentation to Tricare’s pharmacy benefit manager, Express Scripts, demonstrating the following:

1. Diagnosis of Type 2 Diabetes: The beneficiary must have a confirmed diagnosis of Type 2 diabetes, supported by lab results (e.g., HbA1c levels). For weight loss, documentation must show obesity (BMI ≥30 or ≥27 with comorbidities) and diabetes.
2. Failure of First-Line Therapies: Tricare requires evidence that the beneficiary has tried and failed to achieve glycemic control with metformin or other oral antidiabetics for at least 3–6 months. If Ozempic is prescribed for weight loss, providers must show that lifestyle interventions (diet, exercise) were ineffective.
3. Step Therapy: Tricare often requires beneficiaries to try lower-cost GLP-1 agonists (e.g., Trulicity, Victoza) before approving Ozempic. If these alternatives are contraindicated or ineffective, providers must justify the need for Ozempic.
4. Medical Necessity: Providers must explain why Ozempic is the most appropriate treatment, including its benefits over other therapies (e.g., once-weekly dosing, weight-loss effects, or reduced hypoglycemia risk).

The prior authorization process typically takes 5–10 business days. If denied, beneficiaries can appeal the decision (see next section). To streamline approval, providers should submit complete documentation, including lab results, medication history, and a detailed treatment plan.

How to Get Tricare to Cover Ozempic

Securing Tricare coverage for Ozempic requires a proactive, collaborative approach between beneficiaries and their healthcare providers. Follow these steps to improve the likelihood of approval:

1. Confirm Medical Eligibility: Ensure the prescription aligns with Tricare’s coverage criteria. For diabetes, this means inadequate control with first-line therapies. For weight loss, the beneficiary must have both diabetes and obesity. If the beneficiary does not meet these criteria, Tricare will deny coverage.
2. Work with a Tricare-Aware Provider: Choose a provider familiar with Tricare’s prior authorization process. They should be prepared to document medical necessity, including lab results (e.g., HbA1c, BMI), medication history, and failed therapies. Providers can use Tricare’s prior authorization forms or submit documentation electronically via Express Scripts.
3. Submit a Complete Prior Authorization Request: The provider must include:
   • A detailed letter of medical necessity explaining why Ozempic is the best option.
   • Lab results (e.g., HbA1c levels, lipid panels).
   • Medication history, including doses and durations of prior therapies.
   • Documentation of step therapy, if applicable (e.g., failed trials of metformin or other GLP-1 agonists).
4. Use Tricare’s Preferred Pharmacies: Once approved, fill the prescription at a military pharmacy (if available) to avoid copayments. If not, use Express Scripts’ mail-order service or a Tricare retail network pharmacy to minimize costs.
5. Follow Up: If the prior authorization is denied, request a peer-to-peer review with a Tricare medical director. Providers can often overturn denials by clarifying clinical details during these discussions.
6. Appeal if Necessary: If the denial stands, beneficiaries can file a formal appeal (see next section). Appeals are more likely to succeed if new clinical evidence or errors in the initial review are identified.

By following these steps, beneficiaries can navigate Tricare’s system more effectively and increase their chances of obtaining coverage for Ozempic.

What to Do If Tricare Denies Ozempic

If Tricare denies coverage for Ozempic, beneficiaries have multiple avenues for appeal. Denials typically occur when the prior authorization request lacks sufficient clinical justification or fails to meet Tricare’s coverage criteria. Here’s how to respond:

1. Review the Denial Letter: Tricare will send a written explanation outlining the reason for denial. Common reasons include:
   • Lack of medical necessity: The request did not demonstrate that Ozempic is the most appropriate treatment.
   • Failure to meet step therapy requirements: The beneficiary did not try lower-cost alternatives first.
   • Incomplete documentation: Missing lab results, medication history, or provider notes.
2. Request a Peer-to-Peer Review: Before filing a formal appeal, ask your provider to request a peer-to-peer review with a Tricare medical director. During this discussion, the provider can clarify clinical details, such as the beneficiary’s response to prior therapies or the severity of their condition. Peer-to-peer reviews often resolve denials quickly.
3. File a Formal Appeal: If the peer-to-peer review is unsuccessful, submit a written appeal to Tricare. The appeal must include:
   • A letter from the provider explaining why Ozempic is medically necessary.
   • Additional clinical evidence, such as updated lab results or documentation of adverse effects from prior therapies.
   • A copy of the denial letter and any supporting documents. Appeals must be submitted within 90 days of the denial. Tricare will review the case and issue a decision within 30–60 days.
4. Escalate to the Tricare Appeals Board: If the appeal is denied, beneficiaries can request a review by the Tricare Appeals Board. This process is more formal and may require legal or advocacy support. The board’s decision is final.
5. Explore Alternative Coverage: While appealing, consider alternative medications or financial assistance programs (see next section). For example, Novo Nordisk, the manufacturer of Ozempic, offers a patient assistance program that provides the medication at low or no cost to eligible individuals.

Appeals are more likely to succeed if they address the specific reasons for denial. Beneficiaries should work closely with their provider to gather compelling evidence for their case.

Tricare Alternatives If Ozempic Is Not Covered

If Tricare denies coverage for Ozempic or the out-of-pocket costs are prohibitive, beneficiaries have several alternatives to explore:

1. Other GLP-1 Agonists: Tricare may cover lower-cost GLP-1 agonists, such as:
   • Trulicity (dulaglutide): A once-weekly injectable approved for Type 2 diabetes. Tricare often covers it as a Tier 2 medication, resulting in lower copayments.
   • Victoza (liraglutide): A daily injectable for diabetes, also covered under Tricare’s formulary. It may be a suitable alternative if Ozempic is denied.
   • Mounjaro (tirzepatide): A newer GLP-1/GIP agonist approved for diabetes and weight loss. Tricare’s coverage for Mounjaro is expanding in 2026, though prior authorization is still required.
2. Wegovy for Weight Loss: If Ozempic is denied for weight loss, beneficiaries with obesity (BMI ≥30 or ≥27 with comorbidities) may qualify for Wegovy, the FDA-approved version of semaglutide for chronic weight management. Tricare’s coverage for Wegovy is limited but may be approved with strong clinical justification.
3. Lifestyle Interventions: For weight loss, Tricare covers medically supervised weight-loss programs, including nutrition counseling and behavioral therapy. These programs are often fully covered and can complement or replace medication.
4. Manufacturer Assistance Programs: Novo Nordisk offers a patient assistance program for Ozempic, providing the medication at no cost to eligible individuals with financial hardship. Beneficiaries can apply through NovoCare.com.
5. Discount Cards and Coupons: Websites like GoodRx or SingleCare offer discounts on Ozempic, reducing the cost to $800–$1,000 per month without insurance. These savings can be significant for beneficiaries facing high copayments.
6. Clinical Trials: For beneficiaries interested in cutting-edge treatments, participating in a clinical trial for diabetes or obesity medications may provide access to Ozempic or similar drugs at no cost. Trials can be found on ClinicalTrials.gov.

By exploring these alternatives, beneficiaries can find effective treatments for diabetes or weight loss, even if Ozempic is not covered by Tricare.

Frequently Asked Questions

Does Tricare cover Oz